Differential effects of AMPA receptor potentiators and glycine reuptake inhibitors on antipsychotic efficacy and prefrontal glutamatergic transmission

ORG-25935

{Short description|Synthetic drug}}.

ORG-25935

ORG-25935, also known as SCH-900435 is a synthetic drug developed by Organon International, which acts as a selective inhibitor of the glycine transporter GlyT-1.

Org 26576

Org 26576 is an ampakine drug originally developed by Cortex Pharmaceuticals and then licensed to Organon International for development.

Org 26576